Overview

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

Status:
Unknown status

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

To evaluate the time to progression of the combination therapy of Transcatheter Arterial Chemoembolization (TACE) and sorafenib in patients with previously untreated advanced or metastatic hepatocellular carcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Chung-Ang University

Collaborator:

Gyeongsang National University Hospital

Treatments:

Niacinamide
Sorafenib